Qualitative/quantitative detection of infectious pathogenic microorganisms (especially suitable for low-copy microorganisms), pathogen resistance gene mutation detection, pathogen typing and identification
Tumor/cancer-related gene variation (mutation, fusion, methylation, CNV, etc.) detection for early cancer screening, targeted drug therapy, treatment plan guidance, companion diagnosis, efficacy monitoring and evaluation
Non-invasive birth screening using liquid biopsy technology, detection of neonatal genetic diseases such as congenital hypothyroidism and phenylketonuria